SEHK:2609Healthcare
Bayzed Health Group H1 Loss Widening Challenges Long Running Narrative Of Improving Profitability
Bayzed Health Group (SEHK:2609) has reported its FY 2025 first half with revenue of C$574.7 million and a basic EPS loss of C$0.020948, setting the tone for another period where the top line and per share performance remain firmly in focus. Over the recent periods, the company has seen revenue move between C$570.9 million and C$617.9 million per half while basic EPS has ranged from a loss of C$0.00161 to C$0.022396, underscoring a pattern of meaningful sales with persistent, if fluctuating,...